PubMed ID:
26656320
Public Release Type:
Journal
Publication Year: 2016
Affiliation: Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
DOI:
https://doi.org/10.2215/CJN.02560315
Authors:
Greenbaum LA,
Kretzler M,
Mariani LH,
Song P,
Sampson MG,
Licht C,
Zilleruelo GE,
Sambandam KK,
Mokrzycki MH,
Reich HN,
Gibson KL,
Palmer MB,
Cattran DC,
Jennette JC,
Fornoni A,
Barisoni-Thomas L,
Brady TM,
Nast CC,
Lemley KV,
Hingorani SR,
Neu AM,
Avila-Casado C,
Adler SG,
Johnstone DB,
Hodgin JB,
Zhdanova O,
Kopp JB,
Choi MJ,
Hewitt SM,
Meyers KE,
Rosenberg AZ,
Nachman PH,
Hogan SL,
Fervenza FC,
Sethna CB,
Ilori TO,
Lieske JC,
Appel GB,
Dell KM,
Hogan MC,
Bagnasco SM,
Tuttle KR,
Nelson PJ,
Kaskel FJ,
Perumal K,
Moxey-Mims MM,
Holzman LB,
Sedor JR,
Gadegbeku CA,
Trachtman H,
Hladunewich MA,
Lafayette RA,
Troost JP,
Gipson DS
Studies:
Nephrotic Syndrome Study Network
This analysis from the Nephrotic Syndrome Study Network (NEPTUNE) assessed the phenotypic and pathology characteristics of proteinuric patients undergoing kidney biopsy and defined the frequency and factors associated with complete proteinuria remission (CRever).